Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

BACKGROUND: The aim of this study was to assess and compare the Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) and the Choi criteria in evaluating the early response of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) treated with sunitinib. METHODS: Eightee...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yanji, Chen, Jie, Huang, Kun, Lin, Yuan, Chen, Minhu, Xu, Ling, Li, Zi-Ping, Feng, Shi-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324282/
https://www.ncbi.nlm.nih.gov/pubmed/28231773
http://dx.doi.org/10.1186/s12885-017-3150-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324282/
https://www.ncbi.nlm.nih.gov/pubmed/28231773
http://dx.doi.org/10.1186/s12885-017-3150-7

Ejemplares similares